In the current study, we observed marked upregulation of BTLA expression on circulating CD4+ but not CD8+ T cells (Figures 1(a) and 2(a)), which is in consistent with our previous studies on BTLA in tumor-infiltrating T cells in HCC patients [31]. This evidence concerns the gene CD4 and neoplasm.